|
GEMIN5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.43090000004342E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.90280000037058E-08 |
| Normal-vs-Stage2 |
4.246200E-02 |
| Normal-vs-Stage3 |
3.170400E-02 |
| Normal-vs-Stage4 |
2.526000E-02 |
| Stage1-vs-Stage2 |
1.720650E-01 |
| Stage1-vs-Stage3 |
1.065920E-02 |
| Stage1-vs-Stage4 |
1.032590E-01 |
| Stage2-vs-Stage3 |
6.310600E-01 |
| Stage2-vs-Stage4 |
9.680000E-01 |
| Stage3-vs-Stage4 |
6.319000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.80220000040232E-07 |
| Normal-vs-AfricanAmerican |
6.400600E-01 |
| Normal-vs-Asian |
4.066200E-02 |
| Caucasian-vs-AfricanAmerican |
1.207510E-02 |
| Caucasian-vs-Asian |
9.171200E-01 |
| AfricanAmerican-vs-Asian |
2.400800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.91043999999696E-05 |
| Normal-vs-Female |
4.4350999999998E-05 |
| Male-vs-Female |
8.068000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.851410E-01 |
| Normal-vs-Age(41-60Yrs) |
1.66293999999123E-05 |
| Normal-vs-Age(61-80Yrs) |
4.02660000000665E-05 |
| Normal-vs-Age(81-100Yrs) |
2.909400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.447000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.335800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.737400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.197400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.064200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.948200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.426130E-02 |
| Normal-vs-Grade 2 |
8.08029999577187E-08 |
| Normal-vs-Grade 3 |
1.391620E-04 |
| Normal-vs-Grade 4 |
4.473000E-01 |
| Grade 1-vs-Grade 2 |
5.870200E-01 |
| Grade 1-vs-Grade 3 |
3.454400E-01 |
| Grade 1-vs-Grade 4 |
6.389600E-02 |
| Grade 2-vs-Grade 3 |
2.028400E-01 |
| Grade 2-vs-Grade 4 |
2.263600E-03 |
| Grade 3-vs-Grade 4 |
4.481800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.76985118069706E-12 |
| Normal-vs-ccB subtype |
5.354300E-02 |
| ccA subtype-vs-ccB subtype |
4.80209999986769E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.986500E-04 |
| Normal-vs-N1 |
3.499000E-01 |
| N0-vs-N1 |
7.537400E-01 |
|
|
